# BioNexus Gene Lab Corp: Form 8-K, filed Aug 26, 2024

- Company: [BioNexus Gene Lab Corp](/companies/bglc.md) (CIK 1737523)
- Form: 8-K
- Filed: 2024-08-26
- Accepted by EDGAR: Aug 26, 2024, 16:05 ET
- Period: 2024-08-26
- Accession: 0001477932-24-005269
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737523/000147793224005269/bglc_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737523/000147793224005269/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737523/000147793224005269/bglc_8k.htm

Filed Aug 26, 2024.
Source: SEC EDGAR, the filing index for accession 0001477932-24-005269. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.